Pacira BioSciences, Inc. Gross Profit 2009–2025
Pacira BioSciences, Inc. reported $576.66M of gross profit for fiscal 2025. That was 8.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +84.6%.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $576.66M | 79.4% | +8.7% |
| FY 2024 | $530.54M | 75.7% | +8.2% |
| FY 2023 | $490.31M | 72.6% | +4.9% |
| FY 2022 | $467.53M | 70.1% | +16.5% |
| FY 2021 | $401.28M | 74.1% | +28.5% |
| FY 2020 | $312.32M | 72.7% | -0.6% |
| FY 2019 | $314.31M | 74.7% | +25.5% |
| FY 2018 | $250.43M | 74.3% | +26.0% |
| FY 2017 | $198.72M | 69.3% | +19.5% |
| FY 2016 | $166.27M | 60.2% | -6.1% |
| FY 2015 | $177.16M | 71.1% | +47.4% |
| FY 2014 | $120.23M | 60.8% | +290.6% |
| FY 2013 | $30.78M | 36.0% | +343.2% |
| FY 2012 | $6.95M | 17.8% | +761.4% |
| FY 2011 | $-1.05M | -6.7% | -145.9% |
| FY 2010 | $2.29M | 15.7% | -15.5% |
| FY 2009 | $2.71M | 18.0% | — |
Source: Pacira BioSciences, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open PCRX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Pacira BioSciences, Inc. reported $576.66M of gross profit for fiscal 2025. That was 8.7% higher than fiscal 2024. Compared with fiscal 2020, the change was +84.6%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Pacira BioSciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePacira BioSciences, Inc. — frequently asked questions
What is Pacira BioSciences, Inc.'s gross profit?
Pacira BioSciences, Inc. (PCRX) reported gross profit of $576.66M for fiscal year 2025, per its SEC filings.
How has Pacira BioSciences, Inc.'s gross profit changed over time?
Between fiscal 2009 and 2025, PCRX's gross profit grew at roughly 39.8% per year (compound annual rate), from $2.71M to $576.66M.
Where does this data come from?
Figures are computed from Pacira BioSciences, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.